drugset / Trial / NCT07020988

A Study to Assess the Time to Onset of Action of Staccato Alprazolam Versus Midazolam and Diazepam in Healthy Participants

NCT07020988

Phase 1 Completed 55 enrolled UCB Biopharma SRL
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to estimate the difference in the time to onset of action between Staccato alprazolam and intravenous (iv) midazolam using changes in power in the combined spindle and β1 frequency bands in the qEEG (quantitative electroencephalogram).

Timeline

Start
2025-06-12
Primary completion
2026-01-06
Completion
2026-01-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Alprazolam Small molecule
Subject Diazepam Small molecule Intranasal
Subject Midazolam Small molecule Intravenous

Indications

No indication recorded.